Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jeffrey Montgomery

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
52
2024
165
9.410
Why?
Cystectomy
31
2024
51
6.030
Why?
Prostatic Neoplasms
43
2024
400
4.870
Why?
Kidney Neoplasms
22
2018
181
2.650
Why?
Carcinoma, Transitional Cell
13
2023
54
2.570
Why?
Prostatectomy
22
2023
84
2.260
Why?
Nephrectomy
19
2016
82
1.910
Why?
Lymph Node Excision
7
2024
133
1.750
Why?
Urinary Diversion
6
2021
43
1.570
Why?
Prostate
14
2024
117
1.480
Why?
Laparoscopy
13
2014
181
1.470
Why?
Quality of Life
12
2023
882
1.390
Why?
Aged
81
2024
10191
1.270
Why?
Male
120
2024
26863
1.190
Why?
Middle Aged
87
2024
13096
1.130
Why?
Humans
149
2024
52593
1.120
Why?
Neoadjuvant Therapy
12
2024
125
1.090
Why?
Neoplasm Staging
25
2024
768
0.980
Why?
BCG Vaccine
7
2024
16
0.940
Why?
Robotics
8
2015
43
0.930
Why?
Postoperative Complications
15
2021
1081
0.880
Why?
Retrospective Studies
52
2024
6671
0.870
Why?
Carcinoma, Renal Cell
10
2016
111
0.870
Why?
Penile Neoplasms
3
2024
44
0.850
Why?
Exercise Therapy
1
2023
100
0.790
Why?
Ureter
3
2016
36
0.790
Why?
Exercise
2
2023
548
0.760
Why?
Hernia
2
2020
7
0.740
Why?
Neoplasm Recurrence, Local
15
2024
643
0.690
Why?
Intestine, Small
2
2020
115
0.690
Why?
Physical Fitness
1
2020
57
0.660
Why?
Treatment Outcome
30
2024
5486
0.660
Why?
Herniorrhaphy
1
2020
34
0.660
Why?
Intestinal Obstruction
1
2020
38
0.650
Why?
Patient Readmission
6
2021
246
0.640
Why?
Image-Guided Biopsy
6
2024
34
0.630
Why?
Aged, 80 and over
26
2024
3420
0.620
Why?
Watchful Waiting
7
2019
28
0.610
Why?
Biopsy
17
2023
607
0.590
Why?
Ureteral Neoplasms
2
2018
11
0.580
Why?
Neoplasm Invasiveness
14
2024
278
0.580
Why?
Female
59
2024
28262
0.550
Why?
Testicular Neoplasms
4
2024
46
0.530
Why?
Magnetic Resonance Imaging
10
2023
1545
0.530
Why?
Urinary Bladder
7
2018
101
0.520
Why?
Convalescence
1
2016
6
0.520
Why?
Carcinoma, Squamous Cell
4
2024
331
0.510
Why?
Neoplasms, Germ Cell and Embryonal
3
2024
20
0.480
Why?
Prospective Studies
17
2024
2457
0.470
Why?
Urothelium
4
2018
19
0.470
Why?
Carcinoma in Situ
4
2024
72
0.470
Why?
Chemotherapy, Adjuvant
8
2024
124
0.460
Why?
Ileum
1
2014
89
0.440
Why?
Urologic Neoplasms
3
2019
12
0.440
Why?
Choline
3
2019
64
0.440
Why?
Neoplasm Grading
13
2020
126
0.430
Why?
Medical Oncology
4
2021
104
0.430
Why?
Quality Indicators, Health Care
1
2013
91
0.390
Why?
Needles
3
2021
25
0.380
Why?
Administration, Intravesical
7
2024
16
0.380
Why?
Urologic Surgical Procedures
3
2016
30
0.380
Why?
Disease Progression
8
2024
873
0.370
Why?
Lymphatic Metastasis
4
2024
211
0.370
Why?
Antineoplastic Agents
3
2021
1221
0.370
Why?
Biopsy, Needle
5
2021
182
0.360
Why?
Prostate-Specific Antigen
8
2021
44
0.360
Why?
Survival Rate
9
2021
952
0.360
Why?
Testicular Diseases
1
2011
11
0.350
Why?
Risk Assessment
10
2019
1350
0.350
Why?
Urogenital Neoplasms
1
2010
9
0.340
Why?
Tumor Burden
6
2016
136
0.340
Why?
Muscle Neoplasms
1
2010
16
0.340
Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.340
Why?
Registries
4
2023
629
0.320
Why?
Fluorine Radioisotopes
2
2019
25
0.320
Why?
Retroperitoneal Space
5
2016
26
0.320
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1031
0.310
Why?
Recovery of Function
2
2023
202
0.310
Why?
Adult
27
2024
14170
0.310
Why?
Psoas Muscles
2
2021
2
0.310
Why?
Self Report
1
2010
215
0.310
Why?
Organ Sparing Treatments
4
2018
57
0.300
Why?
Telomerase
2
2019
26
0.300
Why?
Patient Selection
5
2019
266
0.290
Why?
Urinary Incontinence
3
2023
40
0.280
Why?
Deoxycytidine
3
2024
29
0.280
Why?
Seat Belts
2
2017
17
0.280
Why?
Child Restraint Systems
2
2017
18
0.280
Why?
Urinary Catheterization
1
2007
24
0.280
Why?
Urethral Stricture
1
2007
23
0.270
Why?
Positron-Emission Tomography
2
2019
303
0.270
Why?
Time Factors
13
2020
3000
0.270
Why?
Primary Health Care
1
2011
375
0.270
Why?
Rectum
2
2024
55
0.260
Why?
Cohort Studies
8
2021
1553
0.260
Why?
Tomography, X-Ray Computed
3
2021
1162
0.260
Why?
Guideline Adherence
3
2017
143
0.250
Why?
Length of Stay
6
2020
674
0.250
Why?
Health Status
2
2015
300
0.250
Why?
Patient Discharge
3
2017
326
0.250
Why?
Pain Measurement
2
2017
257
0.250
Why?
Patient Participation
2
2016
69
0.240
Why?
Kidney
4
2014
723
0.230
Why?
Bandages
1
2005
28
0.230
Why?
Carcinoma
2
2018
137
0.230
Why?
Adenoviridae
2
2024
47
0.230
Why?
Surgical Wound Infection
1
2005
117
0.230
Why?
Neurilemmoma
1
2004
24
0.230
Why?
Antimetabolites, Antineoplastic
1
2024
38
0.220
Why?
Age Factors
7
2021
1132
0.220
Why?
Multivariate Analysis
8
2016
602
0.220
Why?
Quality Improvement
3
2016
224
0.220
Why?
Adenocarcinoma
3
2016
404
0.220
Why?
Immunohistochemistry
5
2024
984
0.220
Why?
Organoids
1
2024
39
0.220
Why?
Venous Thrombosis
1
2005
90
0.220
Why?
Perineum
1
2024
26
0.220
Why?
Follow-Up Studies
9
2024
2291
0.210
Why?
Antibiotic Prophylaxis
1
2024
61
0.210
Why?
Decision Making
2
2016
282
0.210
Why?
Clinical Competence
3
2016
404
0.200
Why?
Practice Guidelines as Topic
2
2018
496
0.200
Why?
Urethra
3
2014
98
0.190
Why?
Prognosis
9
2021
2118
0.190
Why?
Erectile Dysfunction
3
2023
93
0.190
Why?
United States
12
2020
5227
0.190
Why?
DNA, Neoplasm
2
2018
146
0.190
Why?
Logistic Models
7
2021
934
0.180
Why?
Vital Statistics
1
2021
3
0.180
Why?
Feasibility Studies
2
2020
403
0.180
Why?
Mandatory Reporting
1
2021
12
0.180
Why?
Death Certificates
1
2021
18
0.180
Why?
DNA Mutational Analysis
3
2018
180
0.180
Why?
Birth Certificates
1
2021
26
0.180
Why?
Cell Transdifferentiation
1
2021
8
0.180
Why?
Cost-Benefit Analysis
2
2019
269
0.180
Why?
Neuroendocrine Cells
1
2021
10
0.180
Why?
Reproducibility of Results
7
2018
1217
0.180
Why?
Urethral Diseases
2
2013
7
0.170
Why?
Radiosurgery
1
2022
129
0.170
Why?
Radiography, Abdominal
1
2020
25
0.170
Why?
Mutation
5
2019
1344
0.170
Why?
Reimbursement, Incentive
1
2020
12
0.170
Why?
Genetic Vectors
1
2020
130
0.170
Why?
Randomized Controlled Trials as Topic
4
2023
600
0.160
Why?
Ablation Techniques
1
2019
19
0.160
Why?
Genetic Therapy
1
2020
122
0.160
Why?
Abdominal Pain
1
2020
85
0.160
Why?
Diagnosis, Differential
2
2020
1048
0.160
Why?
Venous Thromboembolism
1
2020
76
0.160
Why?
Genetic Predisposition to Disease
5
2024
528
0.150
Why?
Adjuvants, Immunologic
3
2024
52
0.150
Why?
Urinary Tract
1
2018
25
0.150
Why?
Lymphocytes
1
2019
149
0.150
Why?
Forecasting
1
2019
154
0.150
Why?
Predictive Value of Tests
6
2018
952
0.150
Why?
Obesity
2
2006
1165
0.150
Why?
Genetic Heterogeneity
1
2018
20
0.150
Why?
RNA, Neoplasm
1
2018
45
0.150
Why?
Patient-Centered Care
1
2020
140
0.150
Why?
Neutrophils
1
2019
148
0.150
Why?
Drug Resistance, Neoplasm
1
2020
327
0.150
Why?
Programmed Cell Death 1 Receptor
1
2018
41
0.140
Why?
Internship and Residency
2
2021
449
0.140
Why?
Retroperitoneal Neoplasms
1
2018
18
0.140
Why?
Orchiectomy
1
2018
38
0.140
Why?
Transurethral Resection of Prostate
1
2018
10
0.140
Why?
Pain, Postoperative
2
2016
169
0.140
Why?
Body Size
1
2017
33
0.140
Why?
Quality Assurance, Health Care
1
2018
149
0.140
Why?
Physician-Patient Relations
2
2016
144
0.140
Why?
Inguinal Canal
1
2017
11
0.140
Why?
Urodynamics
2
2014
23
0.140
Why?
Sarcosine
1
2017
3
0.140
Why?
Amino Acid Transport Systems
1
2017
5
0.140
Why?
Anticoagulants
1
2020
279
0.140
Why?
Databases, Factual
2
2021
715
0.140
Why?
Body Height
1
2017
67
0.130
Why?
Electronic Health Records
1
2020
269
0.130
Why?
Carbon Radioisotopes
1
2017
54
0.130
Why?
Safety
1
2017
80
0.130
Why?
Guidelines as Topic
1
2017
110
0.130
Why?
Disease-Free Survival
5
2016
464
0.130
Why?
Transcriptome
2
2018
368
0.130
Why?
Replantation
1
2016
11
0.130
Why?
Scrotum
2
2015
31
0.130
Why?
Protons
1
2017
71
0.130
Why?
Nomograms
1
2016
7
0.130
Why?
Laparotomy
1
2016
37
0.130
Why?
Natural Orifice Endoscopic Surgery
1
2016
5
0.130
Why?
Research Report
1
2016
18
0.130
Why?
Kaplan-Meier Estimate
5
2017
485
0.120
Why?
Physicians
2
2016
241
0.120
Why?
Urinary Retention
2
2007
7
0.120
Why?
Patient Preference
1
2016
43
0.120
Why?
Ureteral Obstruction
1
2016
62
0.120
Why?
Checklist
1
2016
40
0.120
Why?
Time-to-Treatment
1
2016
78
0.120
Why?
Preoperative Period
3
2021
47
0.120
Why?
Genital Neoplasms, Male
1
2015
2
0.120
Why?
Sensitivity and Specificity
5
2018
883
0.120
Why?
Paget Disease, Extramammary
1
2015
5
0.120
Why?
Social Networking
1
2015
16
0.120
Why?
Body Weight
1
2017
523
0.120
Why?
Lymph Nodes
1
2017
252
0.120
Why?
Feedback
1
2015
52
0.120
Why?
Radiopharmaceuticals
1
2016
205
0.120
Why?
Video Recording
1
2015
79
0.110
Why?
Treatment Failure
2
2017
122
0.110
Why?
Peer Group
1
2015
58
0.110
Why?
Informed Consent
1
2015
96
0.110
Why?
Proto-Oncogene Proteins B-raf
1
2015
80
0.110
Why?
Papilloma, Inverted
1
2014
1
0.110
Why?
Equipment Design
3
2021
288
0.110
Why?
Computer Simulation
1
2015
290
0.110
Why?
Proto-Oncogene Proteins p21(ras)
1
2014
69
0.110
Why?
Blood Loss, Surgical
5
2016
69
0.110
Why?
Matched-Pair Analysis
1
2013
11
0.110
Why?
Urinary Incontinence, Stress
1
2014
32
0.110
Why?
Adenoma
1
2015
113
0.110
Why?
Diffusion of Innovation
1
2013
47
0.110
Why?
Kidney Diseases
1
2016
231
0.110
Why?
Carcinoma, Papillary
1
2014
51
0.110
Why?
General Surgery
1
2015
106
0.110
Why?
Body Mass Index
3
2020
692
0.110
Why?
Technology Transfer
1
2013
2
0.100
Why?
Mitomycin
1
2013
19
0.100
Why?
Longitudinal Studies
2
2018
747
0.100
Why?
Radiotherapy, Adjuvant
2
2018
64
0.100
Why?
Accreditation
1
2013
62
0.100
Why?
Severity of Illness Index
2
2014
1037
0.100
Why?
Peripheral Nerves
1
2013
44
0.100
Why?
Education, Medical, Continuing
1
2013
72
0.100
Why?
Operating Rooms
1
2012
27
0.100
Why?
Community Health Centers
1
2012
30
0.100
Why?
Pathology, Clinical
1
2012
25
0.100
Why?
Referral and Consultation
2
2012
292
0.090
Why?
Receptors, Androgen
2
2002
47
0.090
Why?
Algorithms
1
2015
668
0.090
Why?
Combined Modality Therapy
3
2021
639
0.090
Why?
Neoplasms
1
2021
1308
0.090
Why?
Perioperative Care
1
2011
43
0.090
Why?
Risk Factors
5
2017
3952
0.090
Why?
Seminal Vesicles
2
2022
13
0.080
Why?
Skin Neoplasms
1
2015
500
0.080
Why?
Multicenter Studies as Topic
2
2023
112
0.080
Why?
Phantoms, Imaging
2
2020
119
0.080
Why?
Medicare
3
2020
274
0.080
Why?
Proportional Hazards Models
3
2016
444
0.080
Why?
Markov Chains
2
2019
30
0.080
Why?
Carboplatin
2
2022
57
0.070
Why?
Immunotherapy
1
2010
244
0.070
Why?
SEER Program
3
2014
103
0.070
Why?
Postoperative Care
2
2020
105
0.070
Why?
Healthcare Disparities
1
2011
300
0.070
Why?
Ureteroscopy
1
2007
10
0.070
Why?
Automobiles
2
2017
13
0.070
Why?
Pandemics
2
2023
587
0.070
Why?
Sarcopenia
2
2021
98
0.070
Why?
Chi-Square Distribution
3
2013
295
0.070
Why?
Diverticulum
1
2007
21
0.070
Why?
Incidence
2
2021
1077
0.070
Why?
Peritoneum
1
2007
16
0.070
Why?
Cisplatin
2
2022
285
0.070
Why?
Delphi Technique
2
2018
63
0.070
Why?
Gene Amplification
2
2018
58
0.070
Why?
Aftercare
2
2018
72
0.070
Why?
Societies, Medical
2
2018
202
0.070
Why?
Adrenalectomy
1
2006
31
0.060
Why?
Gene Expression Profiling
2
2024
1110
0.060
Why?
Promoter Regions, Genetic
2
2019
474
0.060
Why?
Postoperative Hemorrhage
1
2006
55
0.060
Why?
Case-Control Studies
3
2014
1202
0.060
Why?
Fibrin Tissue Adhesive
1
2005
12
0.060
Why?
Sex Factors
2
2020
729
0.060
Why?
Hand
1
2005
51
0.060
Why?
Tissue Adhesives
1
2005
14
0.060
Why?
Genomics
2
2018
270
0.060
Why?
Intestines
1
2006
154
0.060
Why?
Suture Techniques
1
2005
60
0.060
Why?
Diabetes Complications
1
2005
125
0.060
Why?
Renal Insufficiency
1
2005
115
0.060
Why?
Chromosomes, Human, Pair 12
1
2024
14
0.060
Why?
Glomerular Filtration Rate
2
2016
130
0.050
Why?
Drug Screening Assays, Antitumor
1
2024
136
0.050
Why?
Vulnerable Populations
1
2024
52
0.050
Why?
Superior Mesenteric Artery Syndrome
1
2004
4
0.050
Why?
Mediastinal Neoplasms
1
2024
18
0.050
Why?
Communication
2
2016
257
0.050
Why?
Intraoperative Complications
1
2005
113
0.050
Why?
Hernia, Inguinal
1
2004
22
0.050
Why?
Phenotype
2
2018
800
0.050
Why?
High-Throughput Nucleotide Sequencing
2
2015
179
0.050
Why?
Cell Line, Tumor
2
2018
1436
0.050
Why?
Neoplasms, Second Primary
1
2024
77
0.050
Why?
Child
3
2024
7229
0.050
Why?
Quality of Health Care
2
2015
188
0.050
Why?
Ischemia
1
2004
154
0.050
Why?
Papillomavirus Infections
2
2015
172
0.050
Why?
Perioperative Period
2
2013
22
0.050
Why?
Trinucleotide Repeats
1
2002
4
0.050
Why?
Chromosome Aberrations
1
2024
297
0.050
Why?
Liver Cirrhosis
1
2005
242
0.050
Why?
Muscles
1
2022
108
0.050
Why?
Odds Ratio
2
2014
568
0.050
Why?
Polymorphism, Restriction Fragment Length
1
2002
66
0.050
Why?
Smoking
1
2005
518
0.050
Why?
Gallium Isotopes
1
2021
2
0.050
Why?
Accidents, Traffic
2
2017
90
0.050
Why?
Gallium Radioisotopes
1
2021
10
0.050
Why?
Edetic Acid
1
2021
14
0.050
Why?
Androgen Antagonists
1
2021
11
0.050
Why?
Radiotherapy, Intensity-Modulated
2
2013
182
0.050
Why?
Geography
1
2021
66
0.050
Why?
Polymorphism, Single Nucleotide
1
2024
506
0.040
Why?
Quarantine
1
2021
12
0.040
Why?
Public Health
1
2023
221
0.040
Why?
Internationality
1
2021
46
0.040
Why?
Neoplasm Metastasis
2
2017
239
0.040
Why?
Drug Dosage Calculations
1
2020
11
0.040
Why?
Motion
1
2020
19
0.040
Why?
Enoxaparin
1
2020
31
0.040
Why?
Finite Element Analysis
1
2020
11
0.040
Why?
Drug Monitoring
1
2020
83
0.040
Why?
Fellowships and Scholarships
1
2021
127
0.040
Why?
Pelvis
1
2020
67
0.040
Why?
Abdomen
1
2020
73
0.040
Why?
DNA-Directed RNA Polymerases
1
2019
12
0.040
Why?
Heparin
1
2020
89
0.040
Why?
Young Adult
2
2024
4337
0.040
Why?
Postoperative Period
1
2020
172
0.040
Why?
Social Behavior
1
2019
73
0.040
Why?
Urine
1
2018
25
0.040
Why?
Cytodiagnosis
1
2018
43
0.040
Why?
Adolescent
2
2024
6737
0.040
Why?
Diagnostic Errors
1
2018
69
0.040
Why?
Single-Blind Method
1
2018
116
0.040
Why?
DNA Copy Number Variations
1
2018
117
0.040
Why?
Genome, Human
1
2018
121
0.040
Why?
Quality-Adjusted Life Years
1
2018
67
0.040
Why?
Image Processing, Computer-Assisted
1
2019
246
0.040
Why?
Sequence Analysis, RNA
1
2018
99
0.040
Why?
Delivery of Health Care, Integrated
1
2018
49
0.030
Why?
Random Allocation
1
2018
287
0.030
Why?
Health Services Accessibility
2
2012
438
0.030
Why?
Hospitalization
2
2017
749
0.030
Why?
Nephrons
1
2016
6
0.030
Why?
Tissue Distribution
1
2017
173
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1378
0.030
Why?
Consensus
1
2018
190
0.030
Why?
Hospital Communication Systems
1
2016
5
0.030
Why?
Coitus
1
2016
18
0.030
Why?
Failure to Thrive
1
2016
19
0.030
Why?
Salvage Therapy
1
2017
136
0.030
Why?
Anastomosis, Surgical
1
2016
70
0.030
Why?
Creatinine
1
2016
159
0.030
Why?
Radiometry
1
2017
127
0.030
Why?
Molecular Imaging
1
2016
28
0.030
Why?
Early Detection of Cancer
1
2018
183
0.030
Why?
Cyclin-Dependent Kinase 4
1
2015
10
0.030
Why?
Multiplex Polymerase Chain Reaction
1
2015
12
0.030
Why?
Genes, erbB-1
1
2015
9
0.030
Why?
Operative Time
1
2016
77
0.030
Why?
Tape Recording
1
2015
7
0.030
Why?
Fever
1
2016
113
0.030
Why?
Learning Curve
1
2015
19
0.030
Why?
Socioeconomic Factors
2
2011
606
0.030
Why?
Groin
1
2015
16
0.030
Why?
Tissue Array Analysis
1
2015
46
0.030
Why?
Oncology Service, Hospital
1
2014
14
0.030
Why?
Clinical Trials, Phase III as Topic
1
2015
48
0.030
Why?
Vinblastine
1
2014
22
0.030
Why?
Europe
1
2014
91
0.030
Why?
North America
1
2014
77
0.030
Why?
Regression Analysis
1
2015
403
0.030
Why?
Incontinence Pads
1
2014
2
0.030
Why?
In Situ Hybridization
1
2014
68
0.030
Why?
Amino Acid Substitution
1
2014
80
0.030
Why?
Personal Satisfaction
1
2014
75
0.030
Why?
Kidney Failure, Chronic
1
2016
216
0.030
Why?
Gene Dosage
1
2014
78
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
857
0.030
Why?
Ultrasonography
1
2016
424
0.030
Why?
Methotrexate
1
2014
77
0.030
Why?
United States Department of Veterans Affairs
1
2015
293
0.030
Why?
Papillomaviridae
1
2014
105
0.030
Why?
Survivors
1
2014
118
0.030
Why?
Anxiety
1
2016
301
0.030
Why?
Dysuria
1
2013
1
0.030
Why?
Cluster Analysis
1
2014
233
0.030
Why?
Anesthesiology
1
2014
44
0.030
Why?
Intention to Treat Analysis
1
2013
30
0.030
Why?
Prevalence
1
2016
1017
0.030
Why?
Sequence Analysis, DNA
1
2014
230
0.030
Why?
Valsalva Maneuver
1
2013
10
0.030
Why?
Stents
1
2016
372
0.030
Why?
Diagnostic Tests, Routine
1
2013
31
0.030
Why?
Health Services Research
1
2013
153
0.030
Why?
Paclitaxel
1
2013
91
0.030
Why?
Doxorubicin
1
2014
241
0.020
Why?
Confidence Intervals
1
2013
159
0.020
Why?
Antibiotics, Antineoplastic
1
2013
79
0.020
Why?
Neutropenia
1
2013
115
0.020
Why?
Thrombocytopenia
1
2013
92
0.020
Why?
Survival Analysis
1
2014
673
0.020
Why?
Angiomyolipoma
1
2012
10
0.020
Why?
Attitude of Health Personnel
1
2015
361
0.020
Why?
Unnecessary Procedures
1
2012
20
0.020
Why?
Tertiary Care Centers
1
2012
83
0.020
Why?
Neoplasm, Residual
1
2013
173
0.020
Why?
Pilot Projects
1
2014
721
0.020
Why?
Neoplasms, Multiple Primary
1
2012
44
0.020
Why?
Biopsy, Fine-Needle
1
2012
107
0.020
Why?
Patient Positioning
1
2011
31
0.020
Why?
Urination Disorders
1
2010
23
0.020
Why?
Disease Management
1
2012
188
0.020
Why?
Organ Size
1
2010
231
0.020
Why?
Comorbidity
1
2012
631
0.020
Why?
Health Status Disparities
1
2011
216
0.020
Why?
Intraoperative Period
1
2007
46
0.020
Why?
Erythrocyte Transfusion
1
2006
53
0.020
Why?
Costs and Cost Analysis
1
2006
96
0.020
Why?
Decision Trees
1
2005
22
0.020
Why?
Portal System
1
2005
17
0.010
Why?
Collateral Circulation
1
2005
38
0.010
Why?
Hypertension, Portal
1
2005
22
0.010
Why?
Reoperation
1
2006
465
0.010
Why?
Blood Transfusion
1
2005
129
0.010
Why?
Short Bowel Syndrome
1
2004
17
0.010
Why?
Necrosis
1
2004
171
0.010
Why?
Liver Transplantation
1
2005
165
0.010
Why?
Polymorphism, Genetic
1
2002
184
0.010
Why?
Genetic Markers
1
2002
109
0.010
Why?
Statistics, Nonparametric
1
2002
196
0.010
Why?
Base Sequence
1
2002
637
0.010
Why?
Polymerase Chain Reaction
1
2002
460
0.010
Why?
Molecular Sequence Data
1
2002
773
0.010
Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description